| Feb 9, 2026 |
Feb 11, 2026 |
Sun Nelson
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2026 |
Feb 11, 2026 |
Jaiman Manasi
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2026 |
Feb 11, 2026 |
Lee Tien-Li
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 11, 2025 |
Dec 12, 2025 |
Sun Nelson
|
CFO |
Buy |
83.8
|
+3,000
|
2.84%
|
✗
|
$43.2K |
| Dec 11, 2025 |
Dec 12, 2025 |
Lee Tien-Li
|
CEO |
Buy |
65.0
|
+7,000
|
0.23%
|
✗
|
$101.4K |
| Oct 15, 2025 |
Oct 16, 2025 |
Lee Tien-Li
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 15, 2025 |
Oct 16, 2025 |
Jones Bryan
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 15, 2025 |
Sep 16, 2025 |
Lee Tien-Li
|
CEO |
Buy |
65.0
|
+10,000
|
0.33%
|
✗
|
$96.6K |
| Sep 10, 2025 |
Sep 12, 2025 |
Lee Tien-Li
|
CEO |
Buy |
72.5
|
+20,000
|
0.67%
|
✗
|
$160.7K |
| Sep 9, 2025 |
Sep 10, 2025 |
Sun Nelson
|
CFO |
Buy |
86.3
|
+6,000
|
6.03%
|
✗
|
$48.4K |
| Aug 28, 2025 |
Aug 29, 2025 |
Lee Tien-Li
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Lee Tien-Li
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Chi Jeffrey
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Jaiman Manasi
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Baynes Roy D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Tong Victor Edward Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Jones Bryan
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Sun Nelson
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 13, 2025 |
Graf Susan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Decheng Capital Global Life Sciences Fund IV, L.P.
|
10% Owner |
Buy |
100.0
|
+1,250,000
|
46.86%
|
✗
|
$20M |
| Feb 14, 2025 |
Feb 19, 2025 |
Chi Jeffrey
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Vickers Venture Fund VI Pte Ltd
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Lee Tien-Li
|
CEO |
Buy |
75.0
|
+16,542
|
0.56%
|
✗
|
$264.7K |
| Feb 14, 2025 |
Feb 19, 2025 |
Sun Nelson
|
CFO |
Buy |
95.0
|
+10,000
|
11.18%
|
✗
|
$160K |
| Feb 14, 2025 |
Feb 19, 2025 |
Cormorant Asset Management, LP
|
Other |
Buy |
100.0
|
+187,500
|
23.43%
|
✗
|
$3M |
|
Feb 12, 2025 |
Decheng Capital Global Life Sciences Fund IV, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Tong Victor Edward Jr
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Jones Bryan
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Sun Nelson
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Baynes Roy D.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Graf Susan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Vickers Venture Fund VI Pte Ltd
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Jaiman Manasi
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Chi Jeffrey
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Lee Tien-Li
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 12, 2025 |
Cormorant Asset Management, LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |